Hikma Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	236	188	205	270	426	323
Trading Asset Securities	-	25	24	22	24	24
Cash & Short-Term Investments	236	213	229	292	450	347
Cash Growth	-9.23%	-6.99%	-21.57%	-35.11%	29.68%	-25.38%
Accounts Receivable	1,069	896	789	777	781	662
Other Receivables	37	77	84	64	95	74
Receivables	1,106	973	873	841	876	736
Inventory	1,082	986	891	776	695	757
Prepaid Expenses	-	73	72	74	65	56
Restricted Cash	-	-	-	-	-	4
Other Current Assets	133	18	35	16	8	22
Total Current Assets	2,557	2,263	2,100	1,999	2,094	1,922
Property, Plant & Equipment	1,373	1,326	1,141	1,081	1,146	1,068
Long-Term Investments	11	62	65	52	46	34
Goodwill	393	382	388	389	285	289
Other Intangible Assets	824	774	712	735	607	587
Long-Term Deferred Tax Assets	294	293	226	192	183	221
Other Long-Term Assets	102	33	48	23	11	14
Total Assets	5,554	5,133	4,680	4,471	4,372	4,135
Accounts Payable	611	358	309	291	262	279
Accrued Expenses	185	439	388	272	305	277
Short-Term Debt	82	21	46	75	64	117
Current Portion of Long-Term Debt	624	621	104	64	48	41
Current Portion of Leases	10	11	11	9	9	10
Current Income Taxes Payable	86	78	74	73	57	72
Current Unearned Revenue	41	28	21	193	213	162
Other Current Liabilities	417	422	386	100	58	70
Total Current Liabilities	2,056	1,978	1,339	1,077	1,016	1,028
Long-Term Debt	798	607	975	1,074	651	692
Long-Term Leases	44	46	55	61	74	72
Long-Term Unearned Revenue	25	30	-	-	-	-
Long-Term Deferred Tax Liabilities	17	18	25	19	24	31
Other Long-Term Liabilities	63	133	77	92	140	164
Total Liabilities	3,003	2,812	2,471	2,323	1,905	1,987
Common Stock	40	40	40	40	42	41
Additional Paid-In Capital	282	282	282	282	282	282
Retained Earnings	2,472	2,362	2,158	2,092	2,189	1,892
Comprehensive Income & Other	-256	-374	-282	-279	-60	-80
Total Common Equity	2,538	2,310	2,198	2,135	2,453	2,135
Minority Interest	13	11	11	13	14	13
Shareholders' Equity	2,551	2,321	2,209	2,148	2,467	2,148
Total Liabilities & Equity	5,554	5,133	4,680	4,471	4,372	4,135
Total Debt	1,558	1,306	1,191	1,283	846	932
Net Cash (Debt)	-1,322	-1,093	-962	-991	-396	-585
Net Cash Per Share	-5.93	-4.89	-4.33	-4.41	-1.70	-2.46
Filing Date Shares Outstanding	221.45	220.43	221.08	220.24	231.5	230.46
Total Common Shares Outstanding	221.45	220.43	221.08	220.24	231.5	230.46
Working Capital	501	285	761	922	1,078	894
Book Value Per Share	11.46	10.48	9.94	9.69	10.60	9.26
Tangible Book Value	1,321	1,154	1,098	1,011	1,561	1,259
Tangible Book Value Per Share	5.97	5.24	4.97	4.59	6.74	5.46
Land	-	851	797	725	676	636
Machinery	-	1,067	1,042	964	934	891
Construction In Progress	-	409	272	262	271	255

Source: S&P Global Market Intelligence. Standard template. Financial Sources.